Warren Knudson
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Warren Knudson has a total of 10 co-authors. Here are the top co-authors by number of shared publications:
Cheryl B. Knudson
3 shared publicationsShigeru Ohno
Department of Biochemistry, Rush Medical College, Rush University Medical Center, 1735 West Harrison Street, Chicago, IL 60612, USA
2 shared publications- Amanda J. Fosang
Royal Children’s Hospital
1 shared publication Geraldine Chow
Department of Biochemistry, Rush Medical College, Rush University Medical Center, Chicago, Illinois 60612, USA
1 shared publicationHee-Jeong Im
1 shared publicationHee‐Jeong Im
Rush Medical College, Rush University Medical Center, Chicago, Illinois
1 shared publication
Latest Publications
- Open Access
- 1 November 2006
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 281 (45) , 34601-34609
Acylation of CD44 and Its Association with Lipid Rafts Are Required for Receptor and Hyaluronan Endocytosis
- 1 November 2006
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 281 (45) , 34601-34609
Open AccessAcylation of CD44 and Its Association with Lipid Rafts Are Required for Receptor and Hyaluronan Endocytosis
- Open Access
- 1 June 2006
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 281 (26) , 17952-17960
Hyaluronan Oligosaccharides Induce Matrix Metalloproteinase 13 via Transcriptional Activation of NFκB and p38 MAP Kinase in Articular Chondrocytes
- 1 June 2006
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 281 (26) , 17952-17960
Open AccessHyaluronan Oligosaccharides Induce Matrix Metalloproteinase 13 via Transcriptional Activation of NFκB and p38 MAP Kinase in Articular Chondrocytes
- Open Access
- 30 January 2006
- Published by Wiley in Arthritis & Rheumatism
- Vol. 54 (2) , 443-454
The accumulation of intracellular ITEGE and DIPEN neoepitopes in bovine articular chondrocytes is mediated by CD44 internalization of hyaluronan
Objective: A dramatic loss of aggrecan proteoglycan from cartilage is associated with osteoarthritis. The fate of residual G1 domains of aggrecan is unknown, but inefficient turnover of these domains may impede subsequent repair and retention of newly synthesized aggrecan. Thus, the objective of this study was to determine whether ITEGE‐ and DIPEN‐containing G1 domains, generated in situ, are internalized by articular chondrocytes, and whether these events are dependent on hyaluronan (HA) and its receptor, CD44.Methods: ITEGE and DIPEN neoepitopes were detected by immunofluorescence staining of bovine articular cartilage chondrocytes treated with or without interleukin‐1α (IL‐1α). Additionally, purified ITEGE‐ or DIPEN‐containing G1 domains were aggregated with HA and then added to articular chondrocytes, articular chondrocytes transfected with CD44▵67, or COS‐7 cells transfected with or without full‐length CD44. Internalized epitopes were distinguished by their resistance to extensive trypsinization of the cell surface.Results: Both ITEGE and DIPEN were visualized within the extracellular cell‐associated matrix of chondrocytes as well as within intracellular vesicles. Following trypsinization, the intracellular accumulation of both epitopes was clearly visible. IL‐1 treatment increased extracellular as well as intracellular ITEGE epitope accumulation. Once internalized, the ITEGE neoepitope became localized within the nucleus and displayed little colocalization with HA, DIPEN, or other G1 domain epitopes. The internalization of both ITEGE and DIPEN G1 domains was dependent on the presence of HA and CD44.Conclusion: One important mechanism for the elimination of residual G1 domains following extracellular degradation of aggrecan is CD44‐mediated co‐internalization with HA.
- 30 January 2006
- Published by Wiley in Arthritis & Rheumatism
- Vol. 54 (2) , 443-454
Open AccessThe accumulation of intracellular ITEGE and DIPEN neoepitopes in bovine articular chondrocytes is mediated by CD44 internalization of hyaluronan
Objective: A dramatic loss of aggrecan proteoglycan from cartilage is associated with osteoarthritis. The fate of residual G1 domains of aggrecan is unknown, but inefficient turnover of these domains may impede subsequent repair and retention of newly synthesized aggrecan. Thus, the objective of this study was to determine whether ITEGE‐ and DIPEN‐containing G1 domains, generated in situ, are internalized by articular chondrocytes, and whether these events are dependent on hyaluronan (HA) and its receptor, CD44.Methods: ITEGE and DIPEN neoepitopes were detected by immunofluorescence staining of bovine articular cartilage chondrocytes treated with or without interleukin‐1α (IL‐1α). Additionally, purified ITEGE‐ or DIPEN‐containing G1 domains were aggregated with HA and then added to articular chondrocytes, articular chondrocytes transfected with CD44▵67, or COS‐7 cells transfected with or without full‐length CD44. Internalized epitopes were distinguished by their resistance to extensive trypsinization of the cell surface.Results: Both ITEGE and DIPEN were visualized within the extracellular cell‐associated matrix of chondrocytes as well as within intracellular vesicles. Following trypsinization, the intracellular accumulation of both epitopes was clearly visible. IL‐1 treatment increased extracellular as well as intracellular ITEGE epitope accumulation. Once internalized, the ITEGE neoepitope became localized within the nucleus and displayed little colocalization with HA, DIPEN, or other G1 domain epitopes. The internalization of both ITEGE and DIPEN G1 domains was dependent on the presence of HA and CD44.Conclusion: One important mechanism for the elimination of residual G1 domains following extracellular degradation of aggrecan is CD44‐mediated co‐internalization with HA.
- Open Access
- 1 July 2005
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 280 (29) , 26904-26912
Characterization of Promoter Elements of the Human HYAL-2 Gene
- 1 July 2005
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 280 (29) , 26904-26912
Open AccessCharacterization of Promoter Elements of the Human HYAL-2 Gene
- Open Access
- 4 March 2005
- Published by Wiley in Arthritis & Rheumatism
- Vol. 52 (3) , 800-809
Hyaluronan oligosaccharide–induced activation of transcription factors in bovine articular chondrocytes
Objective: To document the activity profile of transcription factors following chondrocyte stimulation with hyaluronan (HA) hexasaccharides (HA6) and to determine the expression of genes whose transcriptional activation is tightly associated with the transcription factors.Methods: Nuclear extracts from bovine articular chondrocytes treated with HA6 were subjected to transcription factor protein–DNA array analysis. Electrophoretic mobility shift assay (EMSA) analyses were performed to confirm the results of protein–DNA array. The gene expressions of matrix metalloproteinase 3 (MMP‐3), type II collagen, and cartilage oligomeric matrix protein (COMP) were examined by quantitative real‐time reverse transcription–polymerase chain reaction (RT‐PCR), and protease activity was assessed by casein zymography.Results: In the protein–DNA array analysis, 12 transcription factors were up‐regulated and 2 transcription factors were down‐regulated in the chondrocytes treated with HA6. The transcription factors retinoic acid receptor (RAR), retinoid X receptor (RXR), and Sp‐1 exhibited >2‐fold increased activity by HA6 treatment, as confirmed by EMSA. RT‐PCR analysis showed that the expression levels of MMP‐3, type II collagen, and COMP messenger RNA, which are tightly associated with the activation of RAR, RXR, or Sp‐1, were up‐regulated by treatment with HA6. Addition of high molecular mass HA after HA6 treatment resulted in abrogation of the MMP‐3 induction.Conclusion: These results suggest that HA6 increase the activity of multiple transcription factors in chondrocytes and signal the enhanced expression of key genes involved in cartilage‐matrix remodeling and turnover. The data also demonstrate that high molecular mass HA has a potential to suppress the signaling activated by HA6.
- 4 March 2005
- Published by Wiley in Arthritis & Rheumatism
- Vol. 52 (3) , 800-809
Open AccessHyaluronan oligosaccharide–induced activation of transcription factors in bovine articular chondrocytes
Objective: To document the activity profile of transcription factors following chondrocyte stimulation with hyaluronan (HA) hexasaccharides (HA6) and to determine the expression of genes whose transcriptional activation is tightly associated with the transcription factors.Methods: Nuclear extracts from bovine articular chondrocytes treated with HA6 were subjected to transcription factor protein–DNA array analysis. Electrophoretic mobility shift assay (EMSA) analyses were performed to confirm the results of protein–DNA array. The gene expressions of matrix metalloproteinase 3 (MMP‐3), type II collagen, and cartilage oligomeric matrix protein (COMP) were examined by quantitative real‐time reverse transcription–polymerase chain reaction (RT‐PCR), and protease activity was assessed by casein zymography.Results: In the protein–DNA array analysis, 12 transcription factors were up‐regulated and 2 transcription factors were down‐regulated in the chondrocytes treated with HA6. The transcription factors retinoic acid receptor (RAR), retinoid X receptor (RXR), and Sp‐1 exhibited >2‐fold increased activity by HA6 treatment, as confirmed by EMSA. RT‐PCR analysis showed that the expression levels of MMP‐3, type II collagen, and COMP messenger RNA, which are tightly associated with the activation of RAR, RXR, or Sp‐1, were up‐regulated by treatment with HA6. Addition of high molecular mass HA after HA6 treatment resulted in abrogation of the MMP‐3 induction.Conclusion: These results suggest that HA6 increase the activity of multiple transcription factors in chondrocytes and signal the enhanced expression of key genes involved in cartilage‐matrix remodeling and turnover. The data also demonstrate that high molecular mass HA has a potential to suppress the signaling activated by HA6.
- 1 May 2004
- Published by Elsevier in Osteoarthritis and Cartilage
- Vol. 12 (5) , 374-382
Osteogenic Protein-1 inhibits matrix depletion in a hyaluronan hexasaccharide-induced model of osteoarthritis
- 1 May 2004
- Published by Elsevier in Osteoarthritis and Cartilage
- Vol. 12 (5) , 374-382
Osteogenic Protein-1 inhibits matrix depletion in a hyaluronan hexasaccharide-induced model of osteoarthritis
- Open Access
- 8 December 2003
- Published by Wiley in Arthritis & Rheumatism
- Vol. 48 (12) , 3431-3441
G1 domain of aggrecan cointernalizes with hyaluronan via a CD44‐mediated mechanism in bovine articular chondrocytes
Objective To determine whether aggrecan fragments bound to hyaluronan (HA) can be retained and internalized by articular chondrocytes and whether these events are dependent on HA and its receptor, CD44. An additional objective was to determine whether partial degradation of aggrecan is a prerequisite for internalization. Methods Binding and internalization of a variety of fluorescein isothiocyanate (FITC)– or biotin-labeled HA/proteoglycan probes were investigated on normal bovine articular cartilage chondrocytes, bovine articular chondrocytes transfected with a dominant-negative construct of CD44, or COS-7 cells transfected with wild-type CD44. The probes were defined as being internalized by the presence of label associated with the cells following extensive trypsinization of the cell surface. Results Biotinylated aggrecan fragments bound to FITC-HA were cointernalized in bovine articular chondrocytes or COS-7 cells transfected with CD44. Intracellular vesicles containing FITC-HA colocalized with a fluorescent probe for lysosomes. The internalization of the aggrecan fragments was dependent on the presence of HA as well as the presence of functional CD44. Intact aggrecan/FITC-HA complexes bound to the cell surface but were not internalized. However, following brief trypsin digestion of the aggrecan/HA complex, the remaining proteoglycan fragments were bound and internalized. Conclusion Partially degraded aggrecan fragments (e.g., aggrecan G1 domains bound to HA) can be internalized by articular chondrocytes via a mechanism involving HA/CD44-mediated endocytosis. Further, the presence of an intact aggrecan monomer bound to HA inhibits the internalization of HA as well as HA-bound fragments.
- 8 December 2003
- Published by Wiley in Arthritis & Rheumatism
- Vol. 48 (12) , 3431-3441
Open AccessG1 domain of aggrecan cointernalizes with hyaluronan via a CD44‐mediated mechanism in bovine articular chondrocytes
Objective To determine whether aggrecan fragments bound to hyaluronan (HA) can be retained and internalized by articular chondrocytes and whether these events are dependent on HA and its receptor, CD44. An additional objective was to determine whether partial degradation of aggrecan is a prerequisite for internalization. Methods Binding and internalization of a variety of fluorescein isothiocyanate (FITC)– or biotin-labeled HA/proteoglycan probes were investigated on normal bovine articular cartilage chondrocytes, bovine articular chondrocytes transfected with a dominant-negative construct of CD44, or COS-7 cells transfected with wild-type CD44. The probes were defined as being internalized by the presence of label associated with the cells following extensive trypsinization of the cell surface. Results Biotinylated aggrecan fragments bound to FITC-HA were cointernalized in bovine articular chondrocytes or COS-7 cells transfected with CD44. Intracellular vesicles containing FITC-HA colocalized with a fluorescent probe for lysosomes. The internalization of the aggrecan fragments was dependent on the presence of HA as well as the presence of functional CD44. Intact aggrecan/FITC-HA complexes bound to the cell surface but were not internalized. However, following brief trypsin digestion of the aggrecan/HA complex, the remaining proteoglycan fragments were bound and internalized. Conclusion Partially degraded aggrecan fragments (e.g., aggrecan G1 domains bound to HA) can be internalized by articular chondrocytes via a mechanism involving HA/CD44-mediated endocytosis. Further, the presence of an intact aggrecan monomer bound to HA inhibits the internalization of HA as well as HA-bound fragments.